Rani Therapeutics Holdings (RANI) Tax Provisions (2020 - 2022)
Rani Therapeutics Holdings (RANI) posted quarterly Tax Provisions of -$11000.0 for Q4 2022, up 72.5% year-over-year from -$6376.8 in Q4 2021, and up 89.62% quarter-over-quarter from -$106000.0 in Q3 2022.
Rani Therapeutics Holdings (RANI) Tax Provisions (2020 - 2022) Analysis & Trends
Rani Therapeutics Holdings' Tax Provisions history runs 3 years deep, the most recent figure standing at -$11000.0 for Q4 2022.
- In Q4 2022, Tax Provisions rose 72.5% year-over-year to -$11000.0; the TTM figure through Dec 2023 stood at -$11000.0 (down 111.0% YoY), while the FY2022 annual figure was $100000.0, up 143.9% from the prior year.
- Tax Provisions for Q4 2022 stood at -$11000.0, up from -$106000.0 in the prior quarter.
- The five-year high for Tax Provisions was $154000.0 in Q2 2022, with the low at -$106000.0 in Q3 2022.
- The 3-year median for Tax Provisions is $6000.0 (2020), against an average of $14909.1.
- The sharpest annual moves came in 2021 and 2022: Tax Provisions sank 433.33% in 2021, then jumped 15300.0% in 2022.
- Rani Therapeutics Holdings' Tax Provisions stood at $12000.0 in 2020, then tumbled by 433.33% to -$40000.0 in 2021, then soared by 72.5% to -$11000.0 in 2022.
- Business Quant data shows RANI's Tax Provisions at -$11000.0 in Q4 2022, -$106000.0 in Q3 2022, and $154000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -11,000.00 |
| Sep 30, 2022 | -106,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | -40,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Dec 31, 2020 | 12,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 6,000.00 |